Difficulty: Medium
Average Score: 70%
Practice
Vitamin K is indicated for the treatment of bleeding occurring in patients
Correct answer
C
Rationale
Vitamin K is indicated for the treatment of bleeding occurring in patients with obstructive jaundice. Obstructive jaundice is a condition where there is an obstruction in the bile ducts, leading to the inadequate absorption of fat-soluble vitamins like Vitamin K. Vitamin K plays a crucial role in blood clotting, and its deficiency can lead to excessive bleeding.
Option A, patients being treated with heparin, is incorrect because heparin is an anticoagulant that works by preventing blood clot formation. Vitamin K, on the other hand, promotes blood clotting.
Option B, patients being treated with streptokinase, is incorrect because streptokinase is a thrombolytic agent used to dissolve blood clots. Vitamin K is not indicated for patients receiving this treatment.
Option D, patients with peptic ulcer, is incorrect because Vitamin K is not specifically indicated for bleeding associated with peptic ulcers. The primary treatment for peptic ulcers involves addressing the underlying cause and using medications like proton pump inhibitors or antibiotics for H. pylori infection.
In an educational context, understanding the indications for specific vitamin drugs is important for healthcare professionals to provide optimal patient care. Knowing when to administer Vitamin K, in this case, can be critical in managing bleeding disorders in patients with obstructive jaundice. This knowledge helps ensure appropriate treatment interventions and improves patient outcomes.
Option A, patients being treated with heparin, is incorrect because heparin is an anticoagulant that works by preventing blood clot formation. Vitamin K, on the other hand, promotes blood clotting.
Option B, patients being treated with streptokinase, is incorrect because streptokinase is a thrombolytic agent used to dissolve blood clots. Vitamin K is not indicated for patients receiving this treatment.
Option D, patients with peptic ulcer, is incorrect because Vitamin K is not specifically indicated for bleeding associated with peptic ulcers. The primary treatment for peptic ulcers involves addressing the underlying cause and using medications like proton pump inhibitors or antibiotics for H. pylori infection.
In an educational context, understanding the indications for specific vitamin drugs is important for healthcare professionals to provide optimal patient care. Knowing when to administer Vitamin K, in this case, can be critical in managing bleeding disorders in patients with obstructive jaundice. This knowledge helps ensure appropriate treatment interventions and improves patient outcomes.